English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Shire

Nicholas Gueguen | Jun 30, 2017

Shire study sees reduction in hereditary angioedema episodes using lanadelumab

Ruth de Jauregui | May 3, 2017

Study indicates one bleeding incident every 3-15 seconds among hemophiliacs

Robert Hadley | Apr 28, 2017

Shire’s hashtag campaign focusing on primary immunodeficiency

Keri Carbaugh | Feb 6, 2017

Shire takes lead on rare conditions, CEO says

Keri Carbaugh | Jan 18, 2017

Shire again offers scholarship for students with ADHD

Amanda Rupp | Jun 11, 2016

Shire shareholders approve Baxalta merger

Amanda Rupp | Jun 7, 2016

CHMP gives positive opinion of short bowl syndrome pediatric medicine

Amanda Rupp | Apr 17, 2016

Shire sends application to FDA for chewable Vyvanse tablets

Trending

Patient Daily | Aug 18, 2025

Medfluence Advisors’ Greg Caesar to open ASCENT 2025 with keynote on digital practice growth

Patient Daily | Aug 21, 2025

SoCal Breathe Free doctor on balloon sinuplasty: ‘The procedure itself is pretty quick and effectiveness is pretty high’

Patient Daily | Aug 21, 2025

Otolaryngologist on sinusitis and tooth pain: ‘Inflammation in the bottom of the sinus can cause sensitivity in the teeth’

+ Pharmaceuticals
Patient Daily | Aug 21, 2025

PhRMA director of public affairs on 340B rebate model: "Positive first step toward addressing hospital abuse of the 340B program



Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2025 Patient Daily